BioEnclave hosted a scientific seminar at Omnicare, bringing together BUET professors, clinicians, and healthcare professionals to discuss regenerative wound care and locally developed biomedical solutions.
Event gallery
BioEnclave successfully hosted a scientific seminar titled "From Injury to Recovery: Regenerative Solutions in Wound Care" at Omnicare, bringing together BUET professors, clinicians, and healthcare professionals for an in-depth discussion on the future of wound care and regenerative medicine.
The seminar highlighted the rapid evolution of wound care technologies across the world, emphasizing the transition from conventional dressings to advanced bioactive and regenerative solutions that actively support the body's natural healing process. Speakers discussed how global healthcare systems are increasingly adopting these next-generation approaches, while also noting that Bangladesh continues to face challenges such as limited local manufacturing capacity and dependence on imported wound care products.
Delayed access to advanced wound care technologies often results in prolonged healing times, increased risk of complications, and higher treatment costs for patients.
A significant portion of the discussion focused on the clinical burden of chronic and complex wounds in Bangladesh, including diabetic foot ulcers, pressure injuries, non-healing traumatic wounds, and long-standing surgical wounds. Clinicians emphasized that delayed access to advanced wound care technologies often results in prolonged healing times, increased risk of complications, and higher treatment costs for patients.
Participating physicians shared their clinical experiences with BioEnclave products, including CuraGel and AmnioVive, reporting encouraging outcomes in the management of complex and chronic wounds. Doctors noted improved healing progression in long-standing ulcers, positive responses in diabetic foot ulcer cases, and supportive outcomes in difficult non-healing wounds.
The seminar concluded with a shared vision to advance regenerative medicine in Bangladesh through continued collaboration between researchers, clinicians, and industry partners. BioEnclave reaffirmed its commitment to developing innovative, accessible, and effective wound care technologies aimed at improving patient outcomes and strengthening the future of healthcare in the region.
Keep reading
